Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced it will release its 2021 second quarter financial results on August 3, 2021, after market close. Following the release, management will conduct a live audio webcast at 4:30 p.m. ET, discussing financial results and offering updates. Dial-in details are provided for both U.S. and international listeners. A replay of the conference call will be available until August 10, 2021. The company is dedicated to developing innovative treatments for serious diseases and has a diverse portfolio in neuroscience and oncology.
- Scheduled reporting of second quarter financial results shows commitment to transparency.
- Live audio webcast provides an opportunity for investor engagement.
- None.
DUBLIN, July 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on Tuesday, August 3, 2021 after the close of the financial markets. Company management will host a live audio webcast at 4:30 p.m. ET/9:30 p.m. IST to discuss second quarter 2021 financial results and provide a business and financial update.
Audio webcast/conference call:
U.S. Dial-In Number: +1 855 353 7924
International Dial-In Number: +1 503 343 6056
Passcode: 7187077
A replay of the conference call will be available through August 10, 2021.
Replay U.S. Dial-In Number: +1 855 859 2056
Replay International Dial-In Number: +1 404 537 3406
Passcode: 7187077
Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.
Jazz Pharmaceuticals Contacts: | |
Investors: | Media: |
Andrea N. Flynn, Ph.D. | Jacqueline Kirby |
Vice President, Head, Investor Relations | Vice President, Corporate Affairs & Government Relations |
Jazz Pharmaceuticals plc | Jazz Pharmaceuticals plc |
Ireland, +353 1 634 3211 | Ireland, +353 1 697 2141 |
U.S., +1 650 496 2717 | U.S., +1 215 867 4910 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-report-2021-second-quarter-financial-results-on-august-3-2021-301337769.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When will Jazz Pharmaceuticals report its second quarter 2021 financial results?
What time is the webcast for Jazz Pharmaceuticals' second quarter results?
How can I access the Jazz Pharmaceuticals financial results webcast?
Is there a replay available for the Jazz Pharmaceuticals conference call?
